Cargando…
C(60) fullerene against SARS-CoV-2 coronavirus: an in silico insight
Based on WHO reports the new SARS-CoV-2 coronavirus is currently widespread all over the world. So far > 162 million cases have been confirmed, including > 3 million deaths. Because of the pandemic still spreading across the globe the accomplishment of computational methods to find new potenti...
Autores principales: | Hurmach, Vasyl V., Platonov, Maksim O., Prylutska, Svitlana V., Scharff, Peter, Prylutskyy, Yuriy I., Ritter, Uwe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8423725/ https://www.ncbi.nlm.nih.gov/pubmed/34493768 http://dx.doi.org/10.1038/s41598-021-97268-6 |
Ejemplares similares
-
C(60) Fullerene as Synergistic Agent in Tumor-Inhibitory Doxorubicin Treatment
por: Prylutska, Svitlana, et al.
Publicado: (2014) -
C(60) fullerene and its nanocomplexes with anticancer drugs modulate circulating phagocyte functions and dramatically increase ROS generation in transformed monocytes
por: Skivka, Larysa M., et al.
Publicado: (2018) -
C(60) fullerene attenuates muscle force reduction in a rat during fatigue development
por: Prylutskyy, Yuriy, et al.
Publicado: (2022) -
Effect of C(60) Fullerene on Recovery of Muscle Soleus in Rats after Atrophy Induced by Achillotenotomy
por: Nozdrenko, Dmytro, et al.
Publicado: (2022) -
Complexation with C(60) Fullerene Increases Doxorubicin Efficiency against Leukemic Cells In Vitro
por: Grebinyk, Anna, et al.
Publicado: (2019)